{"doi":"10.1093/neuonc/noad096","title":"Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study","abstract":"BACKGROUND: Ependymoma (EPN) posterior fossa group A (PFA) has the highest rate of recurrence and the worst prognosis of all EPN molecular groups. At relapse, it is typically incurable even with re-resection and re-irradiation. The biology of recurrent PFA remains largely unknown; however, the increasing use of surgery at first recurrence has now provided access to clinical samples to facilitate a better understanding of this. METHODS: In this large longitudinal international multicenter study, we examined matched samples of primary and recurrent disease from PFA patients to investigate the biology of recurrence. RESULTS: DNA methylome derived copy number variants (CNVs) revealed large-scale chromosome gains and losses at recurrence in PFA. CNV changes were dominated by chromosome 1q gain and/or 6q loss, both previously identified as high-risk factors in PFA, which were present in 23% at presentation but increased to 61% at first recurrence. Multivariate survival analyses of this cohort showed that cases with 1q gain or 6q loss at first recurrence were significantly more likely to recur again. Predisposition to 1q+/6q- CNV changes at recurrence correlated with hypomethylation of heterochromatin-associated DNA at presentation. Cellular and molecular analyses revealed that 1q+/6q- PFA had significantly higher proportions of proliferative neuroepithelial undifferentiated progenitors and decreased differentiated neoplastic subpopulations. CONCLUSIONS: This study provides clinically and preclinically actionable insights into the biology of PFA recurrence. The hypomethylation predisposition signature in PFA is a potential risk-classifier for trial stratification. We show that the cellular heterogeneity of PFAs evolves largely because of genetic evolution of neoplastic cells.","journal":"Neuro-Oncology","year":2023,"id":334619,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":21,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9589,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":499368,"name":"Kelsey C. Bertrand","orcid":"0000-0001-6382-5411","position":1,"is_corresponding":false},{"id":1063413,"name":"Kent Riemondy","orcid":"0000-0002-2464-7808","position":2,"is_corresponding":false},{"id":455482,"name":"Dexiang Gao","orcid":"0000-0003-3920-7060","position":3,"is_corresponding":false},{"id":664596,"name":"Yonghua Zhuang","orcid":"0000-0002-1822-2395","position":4,"is_corresponding":false},{"id":281454,"name":"Bridget Sanford","orcid":"0000-0002-2173-0198","position":5,"is_corresponding":false},{"id":896078,"name":"Gregory Norris","orcid":"0000-0002-4131-5282","position":6,"is_corresponding":false},{"id":1063414,"name":"Rebecca Chapman","orcid":"0000-0001-8050-8426","position":7,"is_corresponding":false},{"id":225902,"name":"Rui Fu","orcid":"0000-0001-8183-4549","position":8,"is_corresponding":false},{"id":557133,"name":"Nicholas Willard","orcid":"0000-0003-4912-201X","position":9,"is_corresponding":false},{"id":132337,"name":"Andrea M. Griesinger","orcid":"0000-0002-2831-1009","position":10,"is_corresponding":false},{"id":937257,"name":"Graziella Ribeiro de Sousa","orcid":"0000-0003-1809-8539","position":11,"is_corresponding":false},{"id":281449,"name":"Vladimir Amani","orcid":"0000-0002-2280-2317","position":12,"is_corresponding":false},{"id":132339,"name":"Enrique Grimaldo","orcid":"0009-0003-4956-7585","position":13,"is_corresponding":false},{"id":132348,"name":"Todd Hankinson","orcid":"0000-0002-6288-9496","position":14,"is_corresponding":false},{"id":1064083,"name":"Ffyona Booker","orcid":null,"position":15,"is_corresponding":false},{"id":236600,"name":"Martin Sill","orcid":"0000-0001-7616-7665","position":16,"is_corresponding":false},{"id":416308,"name":"Richard G. Grundy","orcid":"0000-0002-2585-2539","position":17,"is_corresponding":false},{"id":25334,"name":"Kristian W. Pajtler","orcid":"0000-0002-3562-6121","position":18,"is_corresponding":false},{"id":271073,"name":"David W. Ellison","orcid":"0000-0003-1239-7757","position":19,"is_corresponding":false},{"id":132351,"name":"Nicholas K. Foreman","orcid":"0000-0003-4848-4801","position":20,"is_corresponding":false},{"id":896080,"name":"Timothy Ritzmann","orcid":"0000-0002-4438-6588","position":21,"is_corresponding":false},{"id":132340,"name":"Andrew M. Donson","orcid":"0000-0003-1153-6911","position":0,"is_corresponding":true}],"reference_count":39,"raw_metadata":null,"created_at":"2026-07-19T01:09:53.742667Z","pmid":"37246777","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}